14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -4.505 12 days ( 10.81 % )
Last Price $0.89 -1.66 %
High/ Low $0.88 - $0.94 5.42%
Chg 7 Days -4.43 % $0.93 $0.89
Chg 30 Days -10.00 % $0.99 $0.89
Chg 12 mos -22.18 % $1.15 $0.89
Trend - 3 mos -6.29 % Width: 38.38 %
Trend - 12 mos -18.04 % Width: 72.06 %
Pred. range - 3 mos $0.82 - $1.14 -7.53 % - 27.96 %
Pred. range - 12 mos $0.614 - $1.06 -31.13 % - 18.50 %
Short MA avg 3 mos Buy Apr 22, 2024 - 4 days
Long MA avg 3 mos Sell Mar 18, 2024 - 28 days
Short/Long MA avg 3 mos Sell Mar 19, 2024 - 27 days
Short MA avg 12 mos Sell Mar 12, 2024 - 32 days
Long MA avg 12 mos Sell Apr 05, 2024 - 15 days
Short/Long MA avg 12 mos Sell Apr 12, 2024 - 10 days
Pivot Short Buy Apr 19, 2024 - 5 days
Bollinger Buy Apr 19, 2024 - 5 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Chimerix

Chimerix Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midl... CMRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT